AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 152 filers reported holding AMYLYX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,032,340 | -17.1% | 438,686 | -2.3% | 0.00% | 0.0% |
| Q2 2023 | $9,684,542 | +2182.7% | 448,982 | +3005.0% | 0.00% | – |
| Q1 2023 | $424,256 | +47.1% | 14,460 | +85.3% | 0.00% | – |
| Q4 2022 | $288,358 | +3104.0% | 7,804 | +2222.6% | 0.00% | – |
| Q3 2022 | $9,000 | -99.6% | 336 | -99.7% | 0.00% | – |
| Q2 2022 | $2,358,000 | +108.3% | 122,443 | +38.9% | 0.00% | – |
| Q1 2022 | $1,132,000 | – | 88,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpha Wave Global, LP | 930,337 | $27,296,088 | 10.08% |
| Perceptive Advisors | 6,034,644 | $177,056,455 | 5.23% |
| GREAT POINT PARTNERS LLC | 783,795 | $22,996,545 | 4.52% |
| Ghost Tree Capital, LLC | 475,000 | $13,937,000 | 4.12% |
| Altium Capital Management LP | 185,000 | $5,427,900 | 3.01% |
| Boxer Capital, LLC | 2,084,000 | $61,145 | 3.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 789,591 | $23,166,600 | 1.37% |
| EMERALD ADVISERS, LLC | 972,835 | $28,542,979 | 1.37% |
| SECTORAL ASSET MANAGEMENT INC | 242,400 | $7,112,016 | 1.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,984,333 | $58,220,330 | 1.30% |